Argitalpenak (12) JONATAN MARTINEZ GARDEZABAL argitalpenak

2024

  1. Cognitive improvement via cortical cannabinoid receptors and choline-containing lipids

    British Journal of Pharmacology

  2. Frontal Cortex Lipid Alterations During the Onset of Alzheimer’s Disease

    Journal of Alzheimer's Disease, Vol. 98, Núm. 4, pp. 1515-1532

  3. Neurolipid systems: A new target for the treatment of dementia

    Basic and Clinical Pharmacology and Toxicology, Vol. 135, Núm. 3, pp. 225-236

  4. Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease

    Neurobiology of Disease, Vol. 202

2023

  1. Lipid metabolism in dopaminergic neurons influences light entrainment

    Journal of Neurochemistry, Vol. 165, Núm. 3, pp. 379-390

  2. Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer’s Research

    Methods in Molecular Biology (Humana Press Inc.), pp. 245-259

2022

  1. Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion

    ACS Pharmacology and Translational Science, Vol. 5, Núm. 9, pp. 791-802

  2. Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis

    European Journal of Neuroscience, Vol. 55, Núm. 6, pp. 1532-1546

2021

  1. Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging

    JCI Insight, Vol. 6, Núm. 11

  2. Modulation of neurolipid signaling and specific lipid species in the triple transgenic mouse model of alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  3. Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease

    ACS Chemical Neuroscience, Vol. 12, Núm. 12, pp. 2167-2181

2017

  1. Lipid mapping of the rat brain for models of disease

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1859, Núm. 9, pp. 1548-1557